Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

P26.02 A Phase II Trial of Neoadjuvant Osimertinib for Surgically Resectable EGFR-Mutant Non-Small Cell Lung Cancer: Updated Results

Jacqueline V. Aredo,Anatoly Urisman,Matthew A. Gubens,Claire Mulvey,Greg M. Allen,Julia K. Rotow,Daniel Lucas Kerr,Turja Chakrabarti,Bianca Bacaltos, Megan Gee,Kirk Jones,Dara L. Aisner,Tejas Patil,Erin Lynn Schenk,Trever G. Bivona,Jonathan W. Riess,Melissa Coleman,Johannes Ruediger Kratz,David Jablons,Collin M. Blakely

JOURNAL OF CLINICAL ONCOLOGY（2023）

Cited 4|Views21

Key words

Neoadjuvant,osimertinib,EGFR

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined